logo-loader
viewEden Research plc

Eden Research chairman hopes to oversee rise in revenue in coming year along with an increase in R&D activity

Lykele van der Broek said the AIM-listed company - that develops and supplies breakthrough biopesticide products - will, in short order, see crop protection, animal health and consumer products on the market

Crops
He added all of the products have been either developed by Eden itself, or by partners using Eden's terpene and SustaineÔ encapsulation technologies

Eden Research PLC’s (LON:EDEN) chairman, Lykele van der Broek hopes to oversee a rise in revenue in the coming year along with an increase in research and development activity “which will help to advance the company's product pipeline apace.”

In a statement to be delivered to today’s annual general meeting, van der Broek said the AIM-listed company - that develops and supplies breakthrough biopesticide products - will, in short order, see crop protection, animal health and consumer products on the market.

READ: Eden Research starts to bloom as Mevalone sales ratchet up

He added all of the products have been either developed by Eden itself, or by partners using Eden's terpene and SustaineÔ encapsulation technologies.

The chairman said: “Sustaine clearly has such a wide-variety of applications, which is excellent, however, I think the approach being taken by the Company to concentrate its efforts on a handful of different market sectors, initially, is sensible.

“In the longer term, I will strive to help Eden become a significant player in the crop protection, animal health and consumer products sectors, which I believe it can be."

van der Broek also pointed out: “Since retiring from Bayer CropScience, I have sought out just a few companies in which I could take an interest in and spend time challenging and supporting the executive team to grow and develop their businesses using my experience,  and so I was pleased to be offered the role of Chairman at Eden as, after careful consideration, I felt that this business had a lot of potential as well as synergy with my professional background.”

He added: “It seems to me that Eden has invested a significant amount of time and resource to get to where it has got to today and that this is now starting to pay off with commercialisation in full-swing.”

Quick facts: Eden Research plc

Price: 8.625 GBX

AIM:EDEN
Market: AIM
Market Cap: £17.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research plc named herein, including the promotion by the Company of Eden Research plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Eden Research hails agreement with US giant Corteva

Biopesticides specialist Eden Research (LON:EDEN) has signed an exclusive evaluation agreement with Corteva Agriscience, an increasingly more significant global player in the use of greener seed technologies. Eden Research CEO Sean Smith tells Proactive London why the deal represents such a...

on 8/1/20

2 min read